| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 5,183,757 | 4,555,846 | 3,445,552 | 4,430,626 | | Cost of Revenue | 3,210,412 | 3,983,366 | 3,029,510 | 2,198,598 | | | Gross Profit | 1,973,345 | 572,480 | 416,042 | 2,232,028 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,215,884 | 96,693 | 56,832 | 1,747,369 | | Non Recurring | 183,950 |
-
|
-
|
-
| | Others | 252,256 | 203,593 | 201,022 | 209,127 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 321,255 | 272,194 | 158,188 | 275,532 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| (20,236) | | Earnings Before Interest And Taxes | 321,255 | 272,194 | 158,188 | 255,296 | | Interest Expense | 8,476 | 1,057 | 1,665 | (15,647) | | Income Before Tax | 312,779 | 271,137 | 156,523 | 270,943 | | Income Tax Expense | 123,902 | 110,293 | 85,283 | 143,575 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 188,877 | 160,844 | 71,240 | 127,368 | | | Non-recurring Events | | Discontinued Operations |
-
| (2,074) | 99,864 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 188,877 | 158,770 | 171,104 | 127,368 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $188,877 | $158,770 | $171,104 | $127,368 |
|
0.03% Nasdaq 
Income Statement
